Equities

Uni-Bio Science Group Ltd

Uni-Bio Science Group Ltd

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (HKD)0.077
  • Today's Change0.00 / 0.00%
  • Shares traded4.83m
  • 1 Year change+42.59%
  • Beta-0.1982
Data delayed at least 15 minutes, as of Sep 20 2024 09:08 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of HKD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments1299884
Total Receivables, Net605872
Total Inventory363440
Prepaid expenses------
Other current assets, total13106.72
Total current assets238200202
Property, plant & equipment, net1206858
Goodwill, net------
Intangibles, net39248.18
Long term investments----0
Note receivable - long term9.24----
Other long term assets------
Total assets410292268
LIABILITIES
Accounts payable9.315.275.26
Accrued expenses392843
Notes payable/short-term debt3.43110
Current portion long-term debt/capital leases154.014.61
Other current liabilities, total484239
Total current liabilities1159092
Total long term debt387.470.99
Total debt56235.60
Deferred income tax0.43--0
Minority interest------
Other liabilities, total------
Total liabilities1539893
SHAREHOLDERS EQUITY
Common stock646463
Additional paid-in capital752752751
Retained earnings (accumulated deficit)(587)(658)(696)
Treasury stock - common(5.17)----
Unrealized gain (loss)------
Other equity, total343856
Total equity257195174
Total liabilities & shareholders' equity410292268
Total common shares outstanding6,2796,3656,350
Treasury shares - common primary issue8600
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.